Conclusion on the Conformity of the Manufacturer of Drug Products for Medical Use with the Good Manufacturing Practices (GMP)
Shareholders
Pipeline
Media Center
-
Pfizer’s Rare Disease Drug to Be Approved Soon
18 January 2019
-
Environmentally-Friendly Methods in Pharma Industry
18 January 2019
-
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
17 January 2019
-
FDA planning new guidance, hires in cell and gene therapies for 2019
17 January 2019